documents: FDA-2011-D-0605-0060
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2011-D-0605-0060 | FDA | FDA-2011-D-0605 | Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies; Draft Guidance for Industry | Other | Guidance | 2025-11-20T05:00:00Z | 2025 | 11 | 2025-11-20T05:00:00Z | 2026-01-21T04:59:59Z | 2026-01-24T13:16:32Z | 1 | 0 | 09000064b9088de2 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref